Study Title: Emergency Cerclage in Twin Pregnancies at Imminent Risk of Preterm Birth: an Open-Label Randomised Controlled Trial
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Preterm Birth
- Sponsor
- St George's, University of London
- Enrollment
- 31
- Locations
- 1
- Primary Endpoint
- Time to delivery (from randomisation to birth).
- Last Updated
- 7 years ago
Overview
Brief Summary
Twin pregnancies are at an increased risk of early delivery. One of the reasons for this may be due to a weakened neck of the womb (cervix). There are 2 main ways to manage a weakened cervix in pregnancy. One option is to do nothing (conservative approach). The other is to strengthen the cervix with a stitch (cerclage) to provide extra support. There is no good quality convincing evidence to suggest which of these has better outcomes for mum and babies in twin pregnancies. This trial aims to determine whether securing the weakened cervix with a cerclage will help to prolong the pregnancy and prevent early delivery. Babies who are born early experience multiple complications including lung, brain and learning difficulties. Therefore, the study will also aim to determine whether prolonging the pregnancy by inserting the cerclage reduces the number of babies affected by these problems. In order to carry out a fair study we aim to perform what is known as a randomised controlled trial. We will include in the trial two major groups: (1) women pregnant with twins, who present with a weakened cervix and no signs of infection between 14 and 26 weeks of pregnancy. This will be diagnosed on an internal examination or ultrasound scan, and (2) women pregnant with identical twins complicated by twin-to-twin transfusion syndrome (TTTS) treated by Laser surgery between 16 and 26 weeks in whom a short cervix (<15mm) is identified. TTTS is rare but potentially devastating condition which occurs in about 10-15% of identical twin pregnancies. If left untreated, 80-90% of these babies will die. Overall, best first-line treatment of TTTS is laser surgery. Cervical length is a strong predictor of preterm delivery in these pregnancies.
Participants will be allocated randomly into the intervention (cerclage) or control (conservative) group. The procedure to insert the cerclage will be performed under an anaesthetic to minimise discomfort and you will be admitted for 2-3 days following the operation to ensure there are no complications or signs of labour. Women in both groups will be followed up in the same manner until they deliver and the pregnancy outcomes will be compared between the 2 groups to determine which management option is best.
Detailed Description
The study hypothesis is that the placement of an emergency cervical cerclage prolongs the pregnancy in (1) twin pregnancies with a dilated internal cervical os between 14+0 and 26+0 weeks, and (2) in monochorionic twin pregnancies complicated by TTTS treated by Laser surgery between 16+0 and 26+0 weeks' gestation in whom a short cervix (\<15mm) is identified. Study Design: Randomised controlled trial Study population: 2 groups * Twin pregnancies between 14 - 26 weeks' gestation presenting with an open cervix * Monochorionic twin pregnancies complicated by twin-to-twin transfusion syndrome (TTTS) treated by Laser surgery between 16+0 and 26+0 weeks' gestation in whom a short cervix (\<15mm) is identified The primary outcome is time to delivery (from randomisation to birth). Secondary outcomes include gestation at delivery, preterm birth before 28, 32 and 34 weeks' gestation, birthweight, stillbirth, neonatal death, survival to discharge, days of admission to the neonatal intensive care unit, composite outcome of stillbirth, neonatal death, intraventricular haemorrhage, periventricular leukomalacia, respiratory distress syndrome, bronchopulmonary dysplasia, retinopathy of prematurity, necrotising entercolitis, proven neonatal sepsis, or the need for ventilation, days of maternal admission for preterm labour and maternal morbidity.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Twin pregnancies presenting with an open cervix between 14 and 26 weeks of gestation, OR
- •Twin pregnancies complicated by TTTS treated by Laser surgery between 16+0 and 26+0 weeks' gestation in whom a short cervix (\<15mm) is identified.
- •Age \>18 years
- •Informed consent
Exclusion Criteria
- •Cervical dilatation ≥5cm
- •Amniotic membranes prolapsed beyond external os into the vagina, unable to visualise cervical tissue
- •Preterm premature rupture of the membranes (PPROM) at the time of diagnosis of dilated cervix
- •Major fetal malformations unrelated to TTTS
- •Intrauterine death of one or both fetuses
- •Symptoms or signs of threatened imminent delivery, e.g. painful regular uterine contractions, active vaginal bleeding, history of ruptured membranes
- •Suspected chorioamnionitis \[based on maternal uterine tenderness, a temperature of 38°C or greater, significant leucocytosis (\>15,000 x 106/L) or elevated C-reactive protein (\>15 mg/L), or maternal tachycardia\].
- •Placenta praevia
- •Monochorionic monoamniotic twin pregnancies
- •Prophylactic cervical cerclage
Outcomes
Primary Outcomes
Time to delivery (from randomisation to birth).
Time Frame: 2 weeks after expected date of birth
Time between randomisation and delivery in days
Secondary Outcomes
- Neonatal death(42 days (28 days neonatal period+2 weeks postdates))
- Survival to discharge(42 days (28 days neonatal period+2 weeks postdates))
- Composite outcome(42 days (28 days neonatal period+2 weeks postdates))
- Gestation at delivery(2 weeks after expected date of birth)
- Days of admission to the neonatal intensive care unit(42 days (28 days neonatal period+2 weeks postdates))
- Days of maternal admission for preterm labour(2 weeks after expected date of birth)
- Preterm birth before 28, 32 and 34 weeks' gestation(2 weeks after expected date of birth)
- Birthweight(42 days (28 days neonatal period+2 weeks postdates))
- Stillbirth(42 days (28 days neonatal period+2 weeks postdates))
- Maternal morbidity (defined as thromboembolic complications, chorioamnionitis, urinary tract infection treated with antibiotics, pneumonia, endometritis, eclampsia, HELLP syndrome, death, or any other significant morbidity)(2 weeks after expected date of birth)